KBI BioPharma, Inc Company Profile

16:35 EDT 21st March 2018 | BioPortfolio

KBI BioPharma, Inc. is a contract services organization committed to reducing process development time, decreasing production cost and increasing speed of development for biopharmaceuticals. As part of our comprehensive service offering, we provide a full range of preformulation (conformational and chemical stability), formulation development (lyophilization, liquid, gel, suspension, sterile/non sterile), analytical method development and validation, toxicological supplies, ICH stability studies and quality and regulatory support. Our services are carried out in state-of-the-art laboratories housed in our 341,000 sq. ft. campus in Durham, North Carolina. KBI BioPharma's management and staff utilize their expertise in biopharmaceutical services to deliver a high-quality technical package to our customer.


1101 Hamlin Road
North Carolina
United States of America


Phone: (919) 479-9898
Fax: (919) 620-7786

News Articles [1476 Associated News Articles listed on BioPortfolio]

BioPharma Ambition 2018: Live updates from an all-island event

In between NIBRT site tours and tax workshops in Dublin Castle, Biopharma-Reporter is covering BioPharma Ambition on the Emerald Isle.

BioPharma Dive's 3 predictions for 2018 and beyond

What trends will shape the biopharma industry in 2018? BioPharma Dive's editors took a stab at predicting how the year may unfold for AI, oncology and neuroscience.

ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / January 11, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Array Biopharma, Inc. ("Array Biopharma" or the "Company") (NASDAQ:...

Critical Survey: Galena Biopharma (GALE) vs. Its Peers

Galena Biopharma is one of 116 publicly-traded companies in the "Pharmaceuticals" industry, but how does it compare to its peers? We will compare Galena Biopharma to similar companies based on the str...

ACC CEO leaving to head new biopharma company

American College of Cardiology CEO Shalom “Shal” Jacobovitz is leav

#jobs #lifescience (Senior) Manager, Regulatory Operations – Biopharma

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: (Senior) Manager, Regulatory Operations – Biopharma .MA-Waltham, Direct...

New SAFE-BioPharma Standard Trust List Enables Validation of Digital Signatures in Both US and EU

A newly published SAFE-BioPharma Trust List vastly improves workflows involving sensitive and proprietary electronic documents exchanged between the US and the EU. When incorporat...

RedHill Biopharma Ltd.: RedHill Biopharma Prices Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., 2017-11-08 15:15 CET (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) ("RedHill" or the "Company"), a specialty biopharmac...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Cardene® sr [PDL BioPharma, Inc.]


Recombinate [Baxter Healthcare Corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [Baxter Healthcare Corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [Baxter Healthcare Corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [Baxter Healthcare Corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

The positive impacts of Real-World Data on the challenges facing the evolution of biopharma.

Demand for healthcare services is unprecedented. Society is struggling to afford the cost. Pricing of biopharmaceutical products is under scrutiny, especially by payers and Health Technology Assessmen...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes

ARRY-403 is an investigational new drug being developed by Array BioPharma Inc. for treating Type 2 diabetes. The purpose of this study is to test the safety (potential side effects) and ...

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Companies [130 Associated Companies listed on BioPortfolio]

SAFE-BioPharma Association

SAFE-BioPharma Association ( is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the ...

Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-b...

TenX Biopharma, Inc.

TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights ...

Rentschler Biopharma SE

Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biop...

Exostar and SAFE-BioPharma Association

SAFE-BioPharma manages the SAFE-BioPharma global digital identity and digital signatures standard, developed for and used extensively throughout the biopharmaceutical industry. LO...

More Information about "KBI BioPharma, Inc" on BioPortfolio

We have published hundreds of KBI BioPharma, Inc news stories on BioPortfolio along with dozens of KBI BioPharma, Inc Clinical Trials and PubMed Articles about KBI BioPharma, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KBI BioPharma, Inc Companies in our database. You can also find out about relevant KBI BioPharma, Inc Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record